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When consolidated memories are reactivated, they become labile and, to persist, must undergo a new
stabilization process called reconsolidation. During reactivation, memory is susceptible to pharmacolog-
ical interventions that may improve or impair it. Spermidine (SPD) is an endogenous polyamine that
physiologically modulates the N-methyl-D-aspartate (NMDA) receptor in mammals by binding on the
polyamine-binding site at the NMDA receptor. While polyamine agonists and antagonists of the poly-
amine binding site on the NMDA receptor respectively improve and impair early consolidation, it has
not been deﬁned whether these agents alter memory reconsolidation. Male Wistar rats were trained in
a fear conditioning apparatus using a 0.4 mA footshock as unconditioned stimulus. Twenty four hours
after training, animals were re-exposed to the apparatus in the absence of shock (reactivation session).
Immediately after the reactivation session, SPD (1–30 mg/kg, i.p.) or the antagonist of the polyamine-
binding site at the NMDA receptor, arcaine (0.1–10 mg/kg, i.p.), were injected, and the animals were
tested in the same apparatus 24 h later. Freezing scores at testing were considered a measure of memory.
While SPD (3 and 10 mg/kg) improved, arcaine (1 and 10 mg/kg) impaired memory reconsolidation.
These drugs had no effect on memory if they were administered in the absence of reactivation, or 6 h after
reactivation session. Arcaine (0.1 mg/kg, i.p.) prevented SPD (3 mg/kg)-induced improvement of memory
reconsolidation. Accordingly, SPD (1 mg/kg) prevented arcaine (10 mg/kg)-induced impairment of mem-
ory reconsolidation. The amnesic effect of arcaine was not reversed by arcaine administration prior to
test, ruling out state dependence in this effect. These results suggest that systemic administration of poly-
amine binding site ligands modulate memory reconsolidation.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Memories are not formed instantaneously. After learning
(acquisition), a series of molecular and cellular changes occur in
different brain regions, such as hippocampus, striatum and amyg-
dala, that lead to a progressive memory stabilization (McGaugh,
2000). This process, which initiates immediately after learning
and is time-dependent, has been named ‘‘consolidation’’ (Dudai,
2004; McGaugh, 1966, 2000). During consolidation, memories are
labile and susceptible to positive or negative modulation by differ-
ent means, including pharmacological agents (McGaugh, 1966,
2000). For decades, prevailed the general belief that consolidated
memories could not be modiﬁed (McGaugh, 2000). Several studies,
however, have shown that reactivating or retrieving consolidated
memories renders them labile again, thus requiring a new stabil-
ization process, called reconsolidation (Dudai, 2004; Nader, Schafe,
& Le Doux, 2000; Sara, 2000).ll rights reserved.
bin).Different neurotransmitter systems have been implicated in
memory reconsolidation (Nader & Hardt, 2009; Sara, 2000;
Tronson & Taylor, 2007). Notwithstanding, convincing pharmaco-
logical and neurochemical evidence supports that glutamate
NMDA receptors, particularly those containing a NR2B subunit,
play a major role in this process (Wang, de Oliveira Alvares, &
Nader, 2009). Accordingly, while NMDA receptor antagonists MK-
801, AP5 and ifenprodil disrupt, the NMDA receptor agonist D-
cycloserine improves fear memory reconsolidation in mice and rats
(Ben Mamou, Gamache, & Nader, 2006; Lee, Milton, & Everitt,
2006; Przybyslawski & Sara, 1997; Suzuki et al., 2004). In this re-
gard, it is worth noticing that spermidine (SPD) and spermine,
endogenous polyamines that bind to and modulate NR2B subunit
activity, have been implicated in memory acquisition and consoli-
dation (Johnson, 1996; Shimada, Spangler, London, & Ingram,
1994; Williams, 1997; Williams, Romano, Dichter, & Molinoff,
1991).
Current evidence suggests that polyamines modulate consolida-
tion by interacting with the polyamine-binding site on the NMDA
receptor (Kishi, Ohno, & Watanabe, 1998; Rubin et al., 2004, 2000,
2001; Shimada et al., 1994). In line with this view, the systemic
(Camera, Mello, Ceretta, & Rubin, 2007), intrahippocampal (Berlese
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2000), and intra-amygdalar (Rubin et al., 2004, 2001) administra-
tion of SPD improves the memory of different tasks in rats. SPD-
induced memory facilitation of the inhibitory avoidance task
involves the sequential activation of PKC and PKA/CREB pathways
in the hippocampus (Guerra et al., 2011, 2012).
Although the involvement of NR2B-containing NMDA receptors
in memory reconsolidation has been shown, no study has ad-
dressed whether polyamines, endogenous agonists of these recep-
tors, modulate memory reconsolidation. Therefore, in the current
study we investigated whether SPD and arcaine, respectively an
agonist and an antagonist of the polyamine binding site on the
NMDA receptors, alter fear memory reconsolidation.2. Materials and methods
2.1. Animals
Experimentally naive male Wistar rats (260–360 g), from the
animal house of the Federal University of Santa Maria were used.
The animals were housed four to a cage on a 12-h day/night cycle
(lights on at 7:00 a.m.) at a temperature of 21 C with water and
standard laboratory chow (Guabi, Santa Maria, Rio Grande do Sul,
Brazil) ad libitum. All experimental procedures were conducted
during the light phase of the cycle (from 11:00 a.m. to 4:00
p.m.). All experimental procedures were conducted in accordance
with the policies on the use of animals and humans in neurosci-
ence research, revised and approved by the Society for Neurosci-
ence Research in January 1995 and with the institutional and
national regulations for animal research (process 068/2011).2.2. Drugs
Animals were injected with saline (0.9% NaCl), 1,4-diguanidin-
obutane sulfate (arcaine; Pfaltz & Bauer, Waterbury, CT, USA), or
N-(3- aminopropyl)-1.4-butanediamine trihydrochloride (spermi-
dine; Sigma, St. Louis, MO). All drugs solutions were prepared daily
in saline and injections were performed intraperitoneally (i.p.) in a
1 ml/kg injection volume. Doses were selected based on previous
studies (Camera et al., 2007) and pilot experiments.2.3. Conditioning apparatus
Contextual fear conditioning training, reactivation and test took
place in a fear conditioning chamber (30  25  25 cm), located in
a well-lit room. The front wall and ceiling of the chamber were
made of clear acrylic plastic, whereas the lateral and rear walls
were made of opaque plastic. The ﬂoor of the chamber consisted
of 32 stainless steel rods (3 mm diameter), spaced 1 cm apart
and wired to a shock generator. The chamber was cleaned with
30% ethylic alcohol before and after each rat occupied it.2.4. Behavioral procedure
2.4.1. Contextual fear conditioning
In the conditioning trial each animal was subjected to a single
fear-conditioning training session, as described by Rubin et al.
(2004), with some modiﬁcations. In brief, the rat was placed in
the conditioning chamber (conditioned stimulus, CS) and habitu-
ated to the apparatus (CS) for 3 min. Immediately after habitua-
tion, three 1 s, 0.4 mA footshocks (unconditioned stimulus, US)
were delivered. The shocks were 40 s apart. After the last CS/US
pairing, rats were allowed to stay in the chamber for additional
60 s before returning to their home cages.2.4.2. Reactivation session
Twenty four hours after the conditioning session, the rats were
re-exposed to the conditioning apparatus for 3 min, but no foot-
shocks were delivered. During this time, the rat was observed
every 4 s to assess whether it was in freezing, or not, by a trained
observer who was unaware of the experimental treatment condi-
tions. Behavior was judged as freezing if there was an absence of
any visible movement, except for that required for breathing. Data
were converted to the percentage of samples scored as freezing.2.4.3. Test session
Twenty-four hours after reactivation, each rat was placed back
in the conditioning chamber and a 6-min test was performed. Dur-
ing this time, the rat was observed every 4 s to assess whether it
was in freezing, or not, as described above, and data were con-
verted to the percentage of samples scores as freezing.2.5. Experimental groups
2.5.1. Experiment 1
This experiment was designed to investigate the effect of SPD
on memory reconsolidation. Animals were trained in the fear con-
ditioning apparatus, as described above. Twenty-four hours later,
the animals were subjected to the reactivation session. Immedi-
ately after reactivation session, the animals were injected with sal-
ine or SPD (1, 3, 10 or 30 mg/kg) and, 24 h later, tested in the fear
conditioning apparatus where their freezing responses were
scored, as described above.2.5.2. Experiment 2
This experiment was designed to investigate the effect of
arcaine on memory reconsolidation. Animals were trained in the
fear conditioning apparatus, as described above. Twenty-four after
training, the animals were subjected to the reactivation session.
Immediately after reactivation session, the animals were injected
with saline or arcaine (0.1, 1 or 10 mg/kg) and, 24 h later, tested
in the fear conditioning apparatus where their freezing responses
were scored, as described above.2.5.3. Experiment 3
To evaluate whether the systemic administration of SPD and ar-
caine are speciﬁc for reconsolidation of contextual fear memories
two control experiments were performed. In the ﬁrst, animals were
trained in the fear conditioning apparatus, as described above, but
were not subjected to the memory reactivation session 24 h later
(‘‘no reactivation’’ control). The animals were injected with saline,
SPD (3 mg/kg) or arcaine (10 mg/kg) 24 h after training and, 24 h
later, were tested in the fear conditioning apparatus and had their
freezing responses scored, as described above. The doses of spermi-
dine and arcaine used in this experiment were chosen based on the
dose-response curve experiments (Experiments 1 and 2), which
determined fully effective and non-effective doses for both
compounds.
In order to conﬁrm the speciﬁcity of enhanced or disrupted
reconsolidation by SPD and arcaine, respectively, a second control
experiment was performed. The animals were trained in the fear
conditioning apparatus and 24 h later they were subjected to the
reactivation session, as described above. Six hours after reactiva-
tion session (‘‘delayed infusion’’ control), the animals were injected
with saline, SPD (3 mg/kg) or arcaine (10 mg/kg). Twenty-four
hours after reactivation, the animals were tested in the fear condi-
tioning apparatus and their freezing responses were scored, as
described above.
Training
SPD/SAL
Reactivation
a 24h
Testing
24h
b
Fig. 1. Postreactivation administration of SPD improves reconsolidation of contex-
tual fear memories. (a) Schematic of the experimental design. Rats received an i.p.
injection of SPD (1–30 mg/kg) or saline (0.9% NaCl, 1 ml/kg), immediately after a
reactivation session, and were tested for memory reconsolidation 1 day later. The
dose of 3 and 30 mg/kg (b) was effective at enhancement memory reconsolidation.
p < 0.05 compared with vehicle by the SNK Test. Data are the means + SEM
percentage of freezing in reconsolidation testing session (n = 9–10 animals in each
group).
Training
ARC/SAL
Reactivationa 24h Testing24h
b
Fig. 2. Postreactivation administration of arcaine impairs the reconsolidation of
contextual fear memories. (a) Schematic of the experimental design. Rats received
an i.p. injection of arcaine (0.1–10 mg/kg) or saline (0.9% NaCl, 1 ml/kg), immedi-
ately after a reactivation session, and were tested for memory reconsolidation 1 day
later. p < 0.05 compared with vehicle by the SNK Test. Data are the means + SEM
percentage of freezing in reconsolidation testing session (n = 8 animals in each
group).
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In order to investigate the involvement of polyamine-binding
sites on the NMDA receptor in the effect of polyamines, we initially
administered the polyaminergic agonist, SPD (at a non-effective
dose, determinedby thedose-effect curve shown inFig. 1) toprevent
the deleterious effect of the polyaminergic antagonist arcaine. The
animalswere trained in the fear conditioning apparatus and, 24 h la-
ter, they were subjected to the reactivation session, as described
above. Immediately after reactivation session, the animals were in-
jected with saline or SPD (1 mg/kg) and 15 min later they were in-
jected with saline or arcaine (10 mg/kg) in different ﬂanks.
Twenty-four hours after reactivation, the animals were tested in
the fear conditioning apparatus and their freezing responses were
scored, as described above.
In order to conﬁrm the involvement of polyamine-binding sites
on the NMDA receptor in the effect of polyamines, we administered
thepolyaminergic antagonist arcaine (at a non-effective dose, deter-
mined by dose-effect curve shown in Fig. 2) to prevent the facilita-
tory effect of SPD. The animals were trained in the fear
conditioning apparatus and, 24 h later, they were subjected to the
reactivation session, as described above. Immediately after reactiva-
tion session, the animals were injected with saline or arcaine
(0.1 mg/kg), immediately after reactivation, and saline or SPD
(3 mg/kg) 15 min later, in different ﬂanks. Twenty-four hours after
reactivation, the animals were tested in the fear conditioning appa-
ratus and their freezing responses were scored, as described above.
2.5.5. Experiment 5
This experiment was designed to investigate whether the effect
of arcaine on memory reconsolidation involved state dependence.
Animalswere trained in the fear conditioning apparatus and, 24 h la-
ter, they were subjected to the reactivation session, as described
above. Immediately after reactivation and 30 min before testing,
the animals were injected with saline or arcaine (10 mg/kg).
Twenty-four hours after reactivation session, the animals weretested in the fear conditioning apparatus, where their freezing re-
sponses were scored, as described above.
2.6. Statistics
The data were converted to the percentage of samples scored as
freezing and analyzed by one- or two-way analysis of variance
(ANOVA), depending on the experimental design. Post hoc analyses
were carried out by the Student–Newman–Keuls test, when indi-
cated. A p < 0.05 was considered signiﬁcant.3. Results
3.1. Postreactivation SPD improves reconsolidation of contextual fear
memories biphasically
Fig. 1 shows the effect of SPD (1–30 mg/kg, i.p.) immediately
post-reactivation on the reconsolidation of fear conditioning. As
expected, statistical analysis (one-way ANOVA) of reactivation ses-
sion freezing scores revealed no difference among groups
[F(4,45) = 0.39, p > 0.05], indicating that animals’ behavior was
similar between groups before drug administration. Statistical
analysis (one-way ANOVA) of test freezing scores revealed a signif-
icant effect of drug treatment [F(4,44) = 4.71, p < 0.05]. Post hoc
analysis (SNK) revealed that while 3 and 10 mg/kg SPD increased,
1 and 30 mg/kg SPD had no effect on freezing scores at test. These
results suggest that SPD facilitates memory reconsolidation in a bi-
phasic manner.
3.2. Postreactivation administration of arcaine impairs reconsolidation
of contextual fear memories in a dose-dependent manner
Fig. 2 shows the effect of arcaine (0.1–10 mg/kg, i.p.) immedi-
ately post-reactivation on fear conditioning reconsolidation. One-
Training
SPD/ARC/SAL
b
Reactivation
a 24h
Testing
24h Training
6h SPD/ARC/SAL
Reactivationc 24h Testing24h
d
Fig. 3. SPD and arcaine are speciﬁc for reconsolidation of contextual fear memories. (a) Schematic of the experimental design in the absence of reactivation session. Rats
received an i.p. injection of SPD (3 mg/kg), arcaine (ARC, 10 mg/kg) or saline (0.9% NaCl, 1 ml/kg), 24 h after training in the absence of reactivation session, and were tested for
memory reconsolidation 1 day later (b). (c) Schematic of the experimental design in the delayed administration of SPD and arcaine. Rats received an i.p. injection of SPD
(3 mg/kg), arcaine (ARC, 10 mg/kg) or saline (0.9% NaCl, 1 ml/kg), 6 h after reactivation session, and were tested for memory reconsolidation 1 day later (d). Data are
means + SEM percentage of freezing in the testing session (n = 7–10 animals in each group).
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signiﬁcant differences among groups [F(3,28) = 0.59, p > 0.05]. Sta-
tistical analysis of test session freezing scores revealed a signiﬁcant
effect of pharmacological treatment [F(3,28) = 9.15, p < 0.05]. Post
hoc analysis (SNK) revealed that while 1 and 10 mg/kg arcaine de-
creased, 0.1 mg/kg arcaine did not alter freezing scores. These re-
sults suggest that arcaine impairs memory reconsolidation in a
dose-dependent manner.
3.3. SPD and arcaine speciﬁcally modulate contextual fear
reconsolidation
Fig. 3 shows the effect of SPD (3 mg/kg, i.p.) and arcaine (10 mg/
kg, i.p.) 24 h after training, in the absence of reactivation session
and 6 h after reactivation session, on contextual fear conditioning.
Statistical analysis (one-way ANOVA) revealed that SPD and ar-
caine did not alter contextual fear conditioning in the absence of
reactivation [F(2,18) = 0.41, p > 0.05, Fig. 3b] and that the delayed
injection of SPD and arcaine did not alter contextual fear condition-
ing [F(2,26) = 0.84, p > 0.05, Fig. 3d]. Again, as expected, statistical
analysis of reactivation freezing scores revealed no differences
among groups [F(2,26) = 0.28, p > 0.05, Fig. 3d].
3.4. Involvement of polyamine-binding sites at the NMDA receptor in
the effect of polyamines on reconsolidation of contextual fear
memories
Fig. 4b shows the effect of SPD, at a non-effective dose (1 mg/kg,
immediately post-reactivation) on the impairment of reconsolida-
tion induced by arcaine (10 mg/kg, 15 min post-reactivation).
Fig. 4d shows the effect of arcaine, at a non-effective dose
(0.1 mg/kg, immediately post-reactivation), on the improvement
of reconsolidation of contextual fear conditioning induced by SPD
(3 mg/kg, 15 min post-reactivation). Statistical analysis (one-way
ANOVA) of reactivation freezing scores revealed no differences
among the groups in both experiments [F(3,16) = 1.20, p > 0.05;
F(3,16) = 1.60, p > 0.05, Fig. 4b and d respectively]. On the other
hand, statistical analysis of test freezing scores (two-way ANOVA)
presented in Fig. 4b revealed a signiﬁcant pretreatment (saline or
SPD) versus treatment (saline or arcaine) interaction[F(1,16) = 57.67, p < 0.05]. Post hoc analysis (SNK) revealed that
SPD prevented the impairment of fear conditioning reconsolidation
induced by arcaine. Statistical analysis of test freezing scores
(two-way ANOVA) presented in Fig 4d revealed a signiﬁcant pre-
treatment (saline or arcaine) versus treatment (saline or SPD)
interaction [F(1,16) = 13.50, p < 0.05]. Post hoc analysis (SNK) re-
vealed that arcaine prevented SPD-induced improvement of con-
textual fear conditioning reconsolidation.
3.5. Effect of arcaine on reconsolidation was not caused by state
dependence
Fig. 5 shows the effect of arcaine immediately post-reactivation
and 30 min before testing on contextual fear conditioning scores at
test. Again, statistical analysis of reactivation freezing scores (one-
way ANOVA) revealed no differences among groups [F(3,16) = 0.23,
p > 0.05]. On the other hand, statistical analysis of freezing scores
at test (two-way ANOVA) revealed only a signiﬁcant effect of post-
reactivation pharmacological treatment [F(1,16) = 0.46, p > 0.05].
Post hoc analysis (SNK) conﬁrmed that administration of arcaine
immediately after reactivation impaired reconsolidation regardless
whether arcaine was injected again before test or not. These results
rule out state dependence as a possible explanation for the currently
reported arcaine-induced impairment of reconsolidation.
4. Discussion
The current study showed that while the polyamine SPD im-
proves, arcaine, an antagonist of the polyamine binding site at
the NMDA receptor, impairs the reconsolidation of contextual fear
conditioning.
In a general sense, the current ﬁnding that arcaine disrupts the
reconsolidation of the memory of contextual fear conditioning task
corroborates those studies that have shown that NMDA receptor
antagonists impair memory reconsolidation (Charlier & Tirelli,
2011; Lee et al., 2006; Pedreira, Perez-Cuesta, & Maldonado,
2002). Early studies by Przybyslawski and Sara (1997) have shown
that blocking NMDA receptor with MK-801 up to 1 h after the reac-
tivation session impairs memory reconsolidation, when memory is
assessed 24 h or 48 h later, suggesting that NMDAmodulators have
Training
0min SPD/SAL 
15min ARC/SAL
Reactivationa 24h Testing24h Training Reactivationc 24h Testing24h
0min ARC/SAL 
15min SPD/SAL
Reactivation Testing
d
Reactivation Testing
b
Fig. 4. Involvement of polyamine-binding sites on the NMDA receptor in the effect of polyamines on reconsolidation. (a) Schematic of the experimental design to prevent the
amnesic effect of arcaine by SPD. Rats received an i.p. injection of SPD (1 mg/kg) or saline (0.9% NaCl, 1 ml/kg) immediately and saline (0.9% NaCl, 1 ml/kg) or arcaine (ARC,
10 mg/kg) 15 min after the reactivation session, and were tested for memory reconsolidation 1 day later (b). (c) Schematic of the experimental design to prevent the
facilitatory effect of SPD by arcaine. Rats received an i.p. injection of arcaine (ARC, 0.1 mg/kg) or saline (0.9% NaCl, 1 ml/kg) immediately and SPD (3 mg/kg, i.p.) or saline (0.9%
NaCl, 1 ml/kg) 15 min after the reactivation session, and were tested for memory reconsolidation 1 day later (d). p < 0.05 compared with vehicle by the SNK. Data are
means + SEM percentage of freezing in the testing session (n = 5 animals in each group).
Training
ARC/SAL
Reactivation
a 24h Testing24h
30min pre testing 
ARC/SAL
Reactivation Testing
b
Fig. 5. Effect of arcaine on reconsolidation was not caused by state dependence. (a)
Schematic of the experimental design. Rats received an i.p. injection of arcaine
(ARC, 10 mg/kg) or saline (0.9% NaCl, 1 ml/kg) immediately after reactivation and
30 min before testing, and were tested for memory reconsolidation. p < 0.05
compared with vehicle by the SNK Test. Data are the means + SEM percentage of
freezing in the testing session (n = 5 animals in each group).
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More recently, additional evidence has been gathered indicating
that NR2B-containing NMDA receptors are critical for reconsolida-
tion. Mamou et al. (2006), have shown that NR2B subunits are nec-
essary for transforming stable fear conditioning memories into
labile ones during reactivation in the basolateral amygdala (BLA),
and Wang et al. (2009) have shown a relationship between NR2B
expression and the ability of an auditory fear memory to undergoreconsolidation in the BLA. Interestingly, the deleterious effect of
arcaine on memory reconsolidation was fully prevented by a
non-effective dose of SPD. This is in full agreement with the view
that arcaine and SPD compete for the same binding site at the
NMDA receptor (Reynolds, 1990). Notwithstanding, arcaine inhib-
its [3H]MK801 binding in the absence of added polyamines, imply-
ing a constitutive role of ligand occupation of the polyamine site
for NMDA receptor function (Reynolds, 1990). Therefore, since ar-
caine may alter NMDA receptor function in the absence of poly-
amines, one must be cautious while presuming a physiological
role for endogenous polyamines on memory based only on data
obtained with arcaine.
In the current study we also showed that SPD improves memory
reconsolidation. These results are also in agreementwith those from
Lee et al. (2006) and Yamada, Zushida, Wada, and Sekiguchi (2009),
who have shown that enhancing NMDA receptor-mediated gluta-
matergic transmission with D-cycloserine (DCS), a NMDA receptor
partial agonist, facilitates the reconsolidation of fear conditioning
memory. The currently described biphasic effect of SPD onmemory
reconsolidation is also in agreement with the view that polyamines
modulate the NMDA receptor biphasically (Rock & Macdonald,
1995; Williams, 1997; Williams et al., 1991). Accordingly, poly-
amines, at low micromolar concentrations, enhance [3H]MK-801
and [3H]TCP binding to theNMDA receptor channel,whereas higher
concentrations of polyamines do not alter the binding of these li-
gands, resulting in a biphasic concentration dose–response curve
(Ransom & Stec, 1988; Sacaan & Johnson, 1990; Williams, 1997).
Accordingly, low concentrations of polyamines enhance NMDA-
evoked currents, whereas higher concentrations of polyamines pro-
duce less enhancement of, or inhibit, NMDA receptor currents
(McGurk, Bennett, & Zukin, 1990; Rock &Macdonald, 1995; Sprosen
&Woodruff, 1990; Williams, Dawson, Romano, Dichter, & Molinoff,
1990). Moreover, these results agree with previous studies that
have shown that intrahippocampal or intra-amygdala administra-
tion of SPD improves the memory of the inhibitory avoidance task
(Berlese et al., 2005; Rubin et al., 2000) and fear conditioning (Rubin
et al., 2004) in a biphasic manner.
One must also outline that the facilitatory role of SPD was fully
prevented by the administration of a non-effective dose of arcaine,
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polyamine binding site at the NMDA receptor.
Since we have previously shown that intrahippocampal SPD
facilitates the extinction of fear conditioning (Gomes et al., 2010),
some important methodological differences between the experi-
mental protocols used to investigate extinction and reconsolidation
must be emphasized. Reconsolidation protocols demand a brief
exposure of the animal to the conditioning context (Sara, 2000).
Such a short exposure strengths the association between context
and shock, as context brings about the vivid recall of the traumatic
shock experience. In this case, the duration of exposure is not en-
ough for the animal realize that the conditioned stimulus (CS) does
not predict the unconditioned stimulus (US) anymore. Accordingly,
longer periods of re-exposure to the training context allow such a
dissociation between CS and US. The dissociation between context
and shock implies a new learning (Ji & Maren, 2007; Myers & Davis,
2002; Szapiro, Vianna, McGaugh, Medina, & Izquierdo, 2003) and,
consequently, the formation of a differentmemory (engram). In this
context, it is reasonable that SPD facilitates extinction of fear condi-
tioning (Gomes et al., 2010), because it depends on the activation of
NMDA receptors (Myers & Davis, 2002), particularly those contain-
ing the NR2B subunit (Sotres-Bayon, Diaz-Mataix, Bush, & LeDoux,
2009). Therefore, one might argue that our results (this study and
Gomes et al., 2010) constitute pharmacological evidence supporting
the involvement of the NMDA receptor in fear conditioning recon-
solidation and extinction, as proposed by different authors (Bustos,
Giachero, Maldonado, & Molina, 2010; Lee et al., 2006; Sotres-Ba-
yon, Bush, & LeDoux, 2007; Suzuki et al., 2004;Weber, Hart, & Rich-
ardson, 2007; Yamada et al., 2009).
It is also interesting that the facilitatory effect of SPD onmemory
reconsolidation did not occur when this polyamine was adminis-
tered 6 h after the reactivation session. This timewindow for the ef-
fect of SPD on reconsolidation is similar to that determined for SPD
on early consolidation of inhibitory avoidance (Berlese et al., 2005).
Nader et al. (2000) have shown that reconsolidation is sensitive to
protein synthesis inhibition also at a restricted time window (less
than 6 h), suggesting that both consolidation and reconsolidation
have timewindowswithinwhich protein synthesis is required. Not-
withstanding, it is not knownwhether the facilitatory effects of SPD
on memory depend on protein synthesis, and which cerebral struc-
tures are affected by SPD and arcaine, as well. In this context, micr-
oinfusion studies may provide experimental evidence to answer
these questions.
At last, since previous studies have shown that arcaine causes
state-dependent learning (Ceretta, Camera, Mello, & Rubin, 2008;
Mariani et al., 2011)onemightquestionwhether theeffect of arcaine
on memory reconsolidation is a form of state dependence, i.e., that
retrieval is dependent on a physiological/pharmacological state
present during acquisition (Izquierdo &Dias, 1983a,b,c, 1985; Over-
ton, 1964; Shulz, Sosnik, Ego, Haidarliu, & Ahissar, 2000). However,
the deleterious effect of arcaine onmemory reactivationwas not re-
versed by the administration of arcaine before testing (Fig. 5), ruling
out state-dependent learning in the currently reported effects of
arcaine.
In summary, this study showed that while the systemic injection
of SPD immediately after reactivation improves, the injection of ar-
caine impairs memory reconsolidation. We also showed that sys-
temic injection of arcaine prevents the improvement of memory
reconsolidation induced by SPD and that the injection of SPD pre-
vents arcaine-induced impairment of memory reconsolidation.
These ﬁndings suggest that ligands of the polyamine binding site
at theNMDAreceptormodulatememoryreconsolidation.Moreover,
arcaine-induced impairment of reconsolidation is not related to
state dependence. These results indicate a role for polyamines on
memory reconsolidation.Acknowledgments
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